ELDNEledon Pharmaceuticals, Inc.

ELDN Stock Price, Valuation & Chart | Eledon Pharmaceuticals, Inc.

Compare

$2.990-0.02 (-0.66%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ELDN intrinsic value ELDN calculated fair value vs price

Overview Financials Dividends Ratios

ELDN Historical price chart

ELDN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization230.79M

PE Ratio-3.88

EPS-0.77

Trading Volume1.22M

Today's High/Low3.13/2.92

Dividend Yield0.00

52 Week High/Low4.6/1.35

Shares Outstanding77.19M

ELDN Financial Statement

ELDN Analyst ratings

ELDN Analysis & performance metrics

ELDN Company profile

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic…

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of…

ELDN Management team

Name

Position

Marina Escudero

Vice President & Head of Clinical Operations

Eliezer Katz F.A.C.S., FACS, M.D.

Chief Medical Officer

David Hovland Ph.D.

Chief Regulatory Officer

David-Alexandre C. Gros M.D., Ph.D.CEO

Chief Executive Officer & Non Independent Director

John Herberger

Vice President of Technical Operations

Bryan E. Smith J.D.

General Counsel, Corporate Secretary & Chief Compliance Officer

Paul Sean LittleCFO

Chief Financial Officer

Steven N. Perrin Ph.D.CTO

President, Chief Scientific Officer & Non Independent Director

Name

Position

Marina Escudero

Vice President & Head of Clinical Operations

Eliezer Katz F.A.C.S., FACS, M.D.

Chief Medical Officer

David Hovland Ph.D.

Chief Regulatory Officer

David-Alexandre C. Gros M.D., Ph.D.CEO

Chief Executive Officer & Non Independent Director

John Herberger

Vice President of Technical Operations

Bryan E. Smith J.D.

General Counsel, Corporate Secretary & Chief Compliance Officer

Paul Sean LittleCFO

Chief Financial Officer

Steven N. Perrin Ph.D.CTO

President, Chief Scientific Officer & Non Independent Director

Management Team

Marina Escudero

Vice President & Head of Clinical Operations

Eliezer Katz F.A.C.S., FACS, M.D.

Chief Medical Officer

David Hovland Ph.D.

Chief Regulatory Officer

David-Alexandre C. Gros M.D., Ph.D.CEO

Chief Executive Officer & Non Independent Director

John Herberger

Vice President of Technical Operations

Bryan E. Smith J.D.

General Counsel, Corporate Secretary & Chief Compliance Officer

Paul Sean LittleCFO

Chief Financial Officer

Steven N. Perrin Ph.D.CTO

President, Chief Scientific Officer & Non Independent Director

Management

Marina Escudero

Vice President & Head of Clinical Operations

Eliezer Katz F.A.C.S., FACS, M.D.

Chief Medical Officer

David Hovland Ph.D.

Chief Regulatory Officer

David-Alexandre C. Gros M.D., Ph.D.CEO

Chief Executive Officer & Non Independent Director

John Herberger

Vice President of Technical Operations

Bryan E. Smith J.D.

General Counsel, Corporate Secretary & Chief Compliance Officer

Paul Sean LittleCFO

Chief Financial Officer

Steven N. Perrin Ph.D.CTO

President, Chief Scientific Officer & Non Independent Director

Total 8 executives

ELDN Frequently asked questions

What is Eledon Pharmaceuticals, Inc. (ELDN) Stock Price?

Current stock price of Eledon Pharmaceuticals, Inc. (ELDN) stock is $2.990. The stock price is -0.66% lower in the session. The intraday range can be seen from this page. Volume of Eledon Pharmaceuticals, Inc. (ELDN) stock is 1.22M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Eledon Pharmaceuticals, Inc. (ELDN) stock price going up or down today?

The stock price of Eledon Pharmaceuticals, Inc. (ELDN) can change with earnings, company news, and overall market sentiment. Eledon Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Eledon Pharmaceuticals, Inc. stock expensive at its current price?

Whether Eledon Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ELDN on this page is -3.88. EPS on this page is -0.77. Compare those figures with peers and growth expectations before deciding if the current Eledon Pharmaceuticals, Inc. price is justified.

How has the stock price of Eledon Pharmaceuticals, Inc. (ELDN) performed historically?

Historical performance for Eledon Pharmaceuticals, Inc. (ELDN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ELDN reacted to past earnings and market events.

Should I buy Eledon Pharmaceuticals, Inc. (ELDN) stock, at this price?

Buying Eledon Pharmaceuticals, Inc. (ELDN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.